tiprankstipranks
Avenue Therapeutics Inc (ATXI)
NASDAQ:ATXI
US Market

Avenue Therapeutics (ATXI) Financial Statements

Compare
321 Followers

Avenue Therapeutics Financial Overview

Avenue Therapeutics's market cap is currently $2.88M. The company's EPS TTM is $-14.198; its P/E ratio is ―; Avenue Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -14.54M$ -8.04M$ -3.74M$ -5.21M$ -26.27M
EBITDA$ 4.05M$ 0.00$ 0.00$ -5.21M$ 0.00
Net Income$ -10.38M$ 2.05M$ -3.72M$ -5.09M$ -25.55M
Balance Sheet
Cash & Short-Term Investments$ 1.78M$ 6.71M$ 3.76M$ 3.13M$ 8.74M
Total Assets$ 1.85M$ 6.84M$ 3.96M$ 3.25M$ 8.91M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.78M$ -6.71M$ -3.76M$ -3.13M$ -8.74M
Total Liabilities$ 1.20M$ 3.58M$ 509.00K$ 886.00K$ 2.12M
Stockholders' Equity$ 1.58M$ 3.90M$ 3.45M$ 2.36M$ 6.80M
Cash Flow
Free Cash Flow$ -12.45M$ -7.60M$ -3.75M$ -5.61M$ -26.26M
Operating Cash Flow$ -9.45M$ -7.60M$ -3.75M$ -4.61M$ -26.26M
Investing Cash Flow$ -3.00M$ 0.00$ 0.00$ -1.00M$ 0.00
Financing Cash Flow$ 7.53M$ 10.54M$ 4.38M$ 0.00$ 32.33M
Currency in USD

Avenue Therapeutics Earnings and Revenue History

Avenue Therapeutics Debt to Assets

Avenue Therapeutics Cash Flow

Avenue Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis